1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Czech Republic >
  5. Emmes Acquires Neox s.r.o.

M&A Deal Summary

Emmes Acquires Neox s.r.o.

On December 30, 2020, Emmes acquired life science company Neox s.r.o.

Acquisition Highlights
  • This is Emmes’ 1st transaction in the Life Science sector.
  • This is Emmes’ 1st transaction in Czech Republic.

M&A Deal Summary
Date 2020-12-30
Target Neox s.r.o.
Sector Life Science
Buyer(s) Emmes
Deal Type Add-on Acquisition

Target

Neox s.r.o.

Prague, Czech Republic
Neox s.r.o. provides clinical CRO managing clinical trials through phase I-IV. Oncology, Cardiology, Neurology, Gastroenterology etc. Neox was founded in 2004 and is based in Prague, Czech Republic.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Emmes

Rockville, Maryland, United States
Category Company
Founded 1977
Sector Life Science
Employees600
DESCRIPTION

Emmes is a global, tech-enabled full-service clinical research organization (CRO) platform dedicated to supporting the advancement of public health and biopharmaceutical innovation. Emmes was founded in 1977 and is based in Rockville, Maryland.

DEAL STATS #
Overall 1 of 7
Sector: Life Science M&A 1 of 5
Type: Add-on Acquisition M&A Deals 1 of 7
Country: Czech Republic M&A 1 of 1
Year: 2020 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-12 Orphan Reach

Milton Keynes, United Kingdom

Orphan Reach is a global and full-service CRO that has built a reputation for outstanding clinical research addressing rare diseases. Orphan Reach was founded in 2002 and is based in Milton Keynes, United Kingdom.

Buy -
Mergr

Solution for

Product

Company

Legal